This site uses cookies to provide services, collect traffic data, and personalize ads. You agree by using this site.
More info
Press releases

NEXTCLINICS SOLIDIFIES GROWTH BY ADDING FIRST NORTHERN EUROPEAN IVF CLINIC TO ITS PORTFOLIO

22.03.2019

Tallinn/Augsburg, 22 March 2019: NEXTCLINICS announces it will take control of 100% of F-Est OÜ, the holding company that owns Fertility Clinic Nordic; two ART facilities and a leader in egg and sperm donor program located in Tallinn, Estonia. This is NEXTCLINICS’ first transaction in Northern Europe, providing a third hub for its oocyte and sperm donor programs alongside existing centers in the Czech Republic and Spain. The addition of Fertility Clinic Nordic enlarges NEXTCLINICS’ geographic footprint and is expected boost the number of patients from the Scandinavian and Baltic regions, as well as incoming patients from Central and Western Europe. Fertility Clinic Nordic founder Dr. Jaanus Pikani and his entire management team have reinvested into NEXTCLINICS and will remain in leadership roles as well as manage the F-Est portfolio abroad. In less than two years, NEXTCLINICS has become a top 3 ART provider in Europe with 15 IVF clinics and sites in 8 countries across the continent. The valuation of the Fertility Clinic Nordic transaction will not be disclosed.

“We are dedicated to providing patients with the best experience possible. First and foremost, that means offering them the broadest possible options so they can select the best match for their families. This transaction greatly improves the diversity of our donor options. The Czech Republic and Spain are already two key egg and sperm donor hubs, and Tallinn will now become our third. It will serve the Scandinavian and Baltic countries, which make up approximately 5% of the European ART market,” explains Miroslaw Herden, CEO of NEXTCLINICS.

“For our organization, partnering with NEXTCLINICS offers extended exposure to Central and Western European markets, something that would have been otherwise challenging for an independent clinic. We anticipate growth from patients who are already NEXTCLINICS clients and will travel to Estonia for treatment not currently available in their home markets. We look forward to greater cooperation with the Czech and Spanish clinics with the ambition to continuously assist the growing number of patients who need our help,” said Dr. Jaanus Pikani, new CEO of NEXTCLINICS Estonia and NEXTCLINICS investor.

According to ESHRE statistics*, the ART market in Europe continues to grow. Based on a December 2018 report, year-on-year increases have been registered in a number of IVF clinics in Europe, including the number of IVF and ICSI procedures performed and the number of egg donations offered. Over 750,000 people have sought ART treatment in Europe, of which 42,000 were treated in the Baltic and Scandinavian regions (editor note: Estonia, Latvia, Lithuania, Finland, Sweden, Norway).

NEXTCLINICS European Portfolio

NEXTCLINICS INTERNATIONAL has invested over 200 million EUR over the last 24 months and currently employs over 800 people. Fertility Clinic Nordic joins an ART portfolio that includes 15 clinics and sites in 8 countries including GynePro Medical Group, specialists in the area of reproductive disorders, infertility, and prenatal diagnosis from Bologna and Verona; the ProCrea Group in Lugano offering IVF and specialized diagnostic services as well as plastic surgery and genetic testing; IVF Centers Prof. Zech, one of Europe’s first clinics that today can be found in 5 counties; Praxisklinik Frauenstraße Clinic in Ulm, Germany; IMER in Valencia Spain; and GEST Centre of Reproductive Medicine & Gynecology in Prague, Czech Republic, are both European leaders in egg and sperm donation.

NEXTCLINICS has also invested into other facilities including hospitals, medical laboratories, and a network of blood sampling and tissue collection centers in the Czech Republic, Italy, Germany, Spain, and Switzerland.

About NEXTCLINICS

NEXTCLINICS operates a network of modern and highly-specialized healthcare facilities and offers primarily care in fertility, allergology, clinical immunology, pneumology, as well as other related fields. Entering the European market in 2015, this dynamically-growing healthcare company with headquarters in Germany aims to foster innovative procedures in healthcare combining the latest diagnostic and treatment methods with a patient- and client-centric approach while using cutting-edge communication technology. Services are available in the Czech Republic, Italy, Germany, Luxembourg, Spain, Estonia, and Switzerland. Find more information at www.next-clinics.com.

About Fertility Clinic Nordic

Fertility Clinic Nordic is a dynamic ART clinic founded in 2010. The clinic offers a broad range of fertility services from IVF, preimplantation genetic testing, egg and sperm donation, and social freezing options. The location in Estonia serves as a hub for couples having trouble conceiving for the entire Scandinavian and Norther European region, as well as an attractive location for medical tourism. Combining the latest methods and techniques with a sympathetic and multi-language approach to clients, Fertility Clinic Nordic has established itself among leaders in its field in Northern Europe.

*ESHRE figures: https://www.eshre.eu/Data-collection-and-research/Consortia/EIM/Publications

For more info contact Ewing & Hamburg & K&H



Back to overview

Other articles

NEXTCLINICS MAKES FIRST MAJOR NON-CLINIC ACQUISTION IN EUROPE AND AIMS TO BECOME NUMBER ONE PROVIDER OF BIOLOGICAL MATERIAL IN EUROPEAN ART FIELD

Granada/Augsburg, 11 July 2019: NEXTCLINICS announces it will take control of 100% of Ceifer Biobanco (Ceifer) and YES! Reproduccion (YES!), two of Spain’s leading sperm and egg donor banks located in Granada and Seville. This is NEXTCLINICS’ first major non-IVF clinic transaction in 2019 and one of strategic importance. By way of this acquisition, NEXTCLINICS is fulfilling 2 strategic objectives; continue growth in the ever so important Spanish ART market and offering high-quality, high-volume and diverse biological material for all of its facilities across Europe while at the same time mitigating risk by decreasing dependence on third parties. Ceifer and YES! Founders José Antonio Castilla and Juan Pablo Ramirez and their partner Antonio González have reinvested into NEXTCLINICS and will remain in leadership roles at the clinics in Spain. The valuation of the Ceifer and YES! transaction will not be disclosed.

NEXTCLINICS SOLIDIFIES GROWTH BY ADDING FIRST NORTHERN EUROPEAN IVF CLINIC TO ITS PORTFOLIO

Tallinn/Augsburg, 22 March 2019: NEXTCLINICS announces it will take control of 100% of F-Est OÜ, the holding company that owns Fertility Clinic Nordic; two ART facilities and a leader in egg and sperm donor program located in Tallinn, Estonia. This is NEXTCLINICS’ first transaction in Northern Europe, providing a third hub for its oocyte and sperm donor programs alongside existing centers in the Czech Republic and Spain. The addition of Fertility Clinic Nordic enlarges NEXTCLINICS’ geographic footprint and is expected boost the number of patients from the Scandinavian and Baltic regions, as well as incoming patients from Central and Western Europe. Fertility Clinic Nordic founder Dr. Jaanus Pikani and his entire management team have reinvested into NEXTCLINICS and will remain in leadership roles as well as manage the F-Est portfolio abroad. In less than two years, NEXTCLINICS has become a top 3 ART provider in Europe with 15 IVF clinics and sites in 8 countries across the continent. The valuation of the Fertility Clinic Nordic transaction will not be disclosed.

Press releases overview...




NEXTCLINIC operates a network of modern and highly specialized healthcare facilities and offer care primarily in allergology, clinical immunology, pneumology, phtiseology as well as other related fields. We are a leading provider of assisted reproduction services (IVF), gynecology and obstetrics, and offer a diverse range of complimentary services. Our central fundamental guiding principle lies in a responsible and accountable approach to patients, one where information is shared, and where patients are encouraged to take an active role in their own wellbeing.

With presence on multiple European markets, NEXTCLINIC offers patients from around the world the opportunity to choose a preferred location and enjoy the benefits of unique destinations. Customers enjoy healthcare services, but also a wide range of complimentary services.

Project permeating across several disciplines, providing patients the ability to identify and integrate a whole new social group to gain many benefits. It creates opportunities for testing of your health and makes information about health and healthy lifestyle accessible.

The NEXTLIFE application change trends in patient communication with a physician. We allow quality and fast testing, where the patient can determine the time and method of examination. The NEXTLIFE magazine focuses on a healthy lifestyle.

NEXTLAB provides fast and accurate laboratory diagnostics on biological material for private GPs, outpatient specialists, hospitals, patients without a health insurance policy, and those who request laboratory services beyond standard testing.

NEXTLAB builds upon 20 years of experience with its own labs and sample collection centres, offering a wide range of lab tests based on the latest diagnostic methods, devices and technologies. Tests that are not carried out in our labs are forwarded to partner labs in compliance with a strict pre-analytical procedure.

You are leaving NEXTCLINICS website.

For more information about selected services, you will be redirected to %s.
Do you want to continue?

STAY ON THIS PAGE CONTINUE